Moreover, IRF1, IRF2, IRF3, IRF4, IRF5, IRF7, IRF8, and IRF9 expression increased as tumors progressed, and glioma patients with low expression of these genes had significantly better overall survival. Here, IRF7 is linked to central nervous system cancer.